Nav: Home

Exploring the mystery of how enzymes work via simulations

May 03, 2016

WASHINGTON, D.C., May 10, 2016 - Enzymes play a crucial role in most biological processes--controlling energy transduction, as well as the transcription and translation of genetic information and signaling. They possess a remarkable capacity to accelerate biochemical reactions by many orders of magnitude compared to their uncatalyzed counterparts.

So there is broad scientific interest in understanding the origin of the catalytic power of enzymes on a molecular level. While many hypotheses have been put forward using both experimental and computational approaches, they must be examined critically.

In The Journal of Chemical Physics, from AIP Publishing, a group of University of Southern California (USC) researchers present a critical review of the dynamical concept--time-dependent coupling between protein conformational motions and chemical reactions--that explores all reasonable definitions of what does and does not qualify as a dynamical effect.

The group's work centers on multiscale computer simulations--for which Arieh Warshel, currently a distinguished professor of chemistry at USC, was awarded the 2013 Nobel Prize in chemistry, along with Michael Levitt and Martin Karplus--for exploring the complex actions of enzymes.

"Our study reviews various proposals governing the catalytic efficiency of enzymes, which requires constructing free energy surfaces associated with the chemical reactions, as well as catalytic landscapes comprising conformational and chemical coordinates," explained Ram Prasad Bora, co-author and a postdoctoral assistant working with Warshel. "It's far from trivial to construct these surfaces using reliable theoretical approaches."

For the group's studies, they tend to construct catalytic free energy surfaces by combining an empirical valence bond (EVB) approach, developed by Warshel and colleagues in the early 1980s to determine reaction free energies of enzymatic reactions, with corresponding uncatalyzed solution reaction surfaces constructed via computational "ab initio quantum chemical calculations." But the "quality of EVB free energy surfaces are improved further--to a desired quantum chemical level--by using a paradynamics approach," Bora added.

Comparing the free energy surfaces--and the various factors contributing to these surfaces--for both enzymatic and solution reactions enabled the group to identify the factors contributing to enzyme catalysis.

"In our studies, it's electrostatic free energy," said Bora. "But, to specifically address dynamical and kinetic isotope effects, we used an autocorrelation function of the energy gap, catalytic landscapes--constructed using a renormalization approach--and a quantum classical patch (QCP) approach to determine that dynamics don't contribute to the catalytic power of enzymes."

The key significance of the group's work? "The catalytic activity of enzymes is fundamental to life, so gaining a solid understanding of the factors controlling and contributing to their activity at the molecular level is crucial," said Bora.

With high-quality scientific data now available for the most interesting and complex biological molecules, "it's essential to re-examine various catalytic proposals--especially electrostatic- and dynamic-based proposals," he continued. "Our review focuses on clarifying the role of logical definitions of different catalytic proposals, as well as on the need for a clear formulation in terms of the assumed potential surface and reaction coordinates."

The group determined, in previous efforts, that electrostatic preorganization actually accounts for the observed catalytic effects of enzymes. Their current work focuses on exploring the alternative dynamical proposal.

In terms of applications, the group's enzyme modeling offers "major medical and fundamental value," said Warshel. "For example, it can provide big improvements in enzyme design and advances in drug resistance. Most significant to me, personally, is that it's a solution to the 100-year-old puzzle of how enzymes really do and don't work."

The scientific field of "computational enzyme designing," in particular, stands to benefit from the group's work. "The idea is to tailor desired enzymes for specific purposes--to be used as catalysts for several chemical and biochemical processes at industrial scales--using computational approaches to create artificial enzymes, which can be tested and further improved in laboratories later," explained Bora.

While the concept of designing enzymes computationally from scratch was initially considered intriguing, the field is evolving slowly. "This is largely because the current enzyme designing protocols don't take the actual enzyme catalytic factors into account," Bora continued. "Our work presents a very detailed discussion of these factors, and clarifies that it isn't useful to try to optimize dynamical effects in enzyme design. Focusing on other factors will enable devising future designing protocols on a scientific basis--which will increase the success rate of computationally designed enzymes."

What's next for the group? "More efforts in enzyme design and drug resistance, as well as studies of complex molecular motors and signal transduction," said Warshel.

The group's critical analysis work will help further the exploration of the catalytic factors controlling enzyme catalysis. "Our clear vision about the enzyme catalytic factors means we can now devise effective artificial enzyme design protocols--purely on a scientific basis--that may fill the gap between rational design and laboratory discovery. This can provide insights into another fundamental issue in biology: What controls the evolution of proteins and enzymes?" noted Bora. "Successful design of enzymes may also help in the control of metabolic pathways."
The article, "Perspective: Defining and quantifying the role of dynamics in enzyme catalysis," is authored by Arieh Warshel and Ram Prasad Bora. It will appear in the Journal of Chemical Physics May 10, 2016 (DOI: 10.1063/1.4947037). After that date, it can be accessed at


The Journal of Chemical Physics publishes concise and definitive reports of significant research in the methods and applications of chemical physics. See

American Institute of Physics

Related Drug Resistance Articles:

Fast test can monitor drug resistance in hookworms
More than 2 billion people around the world are infected with intestinal helminths, parasitic worms that can cause disease, complicate pregnancies, and stunt the growth of children.
Resistance to drug of last resort found in farm animals in US
Carbapenems are one of the most important classes of antibiotics used in humans, and are an important agent against multi-drug resistant bacteria.
A cinematic approach to drug resistance
In a creative stroke inspired by Hollywood wizardry, scientists from Harvard Medical School and Technion-Israel Institute of Technology have designed a simple way to observe how bacteria move as they become impervious to drugs.
Salmonella protein reduces drug resistance in tumors
A surprising result in an experiment on Salmonella bacteria has led to a discovery that may make drug resistant cancer cells more treatable by conventional chemotherapies.
Deciphering the mutations behind drug resistance
Antimicrobial resistance in disease-causing microbes has garnered attention in recent years, but another persistent area of drug resistance is the ability for tumors to evade chemotherapy drugs.
Antimalarial resistance to drug not passed on to future generations
Parasites that develop resistance to the antimalarial drug atovaquone cannot pass this resistance on to offspring, a new study suggests, because their lifecycles are often disrupted by the drug's mechanism.
New hybrid drug plugs the hole in malaria drug resistance
The World Health Organization recommends treating malaria with artemisinin combination therapy (ACT), consisting of artemisinin and another drug.
A different route to drug resistance
A team of researchers, led by Ludwig Cancer Research scientist Paul Mischel and James Heath of the California Institute of Technology, has probed biochemical signaling cascades within individual cancer cells to capture a previously poorly understood but clinically significant mechanism of cancer drug resistance.
Mapping the routes to drug resistance in cancer
When a targeted therapy blocks a pathway that enables tumors to grow, the cells usually manage to get around that obstacle.
Resistance to key HIV drug 'concerningly common'
HIV drug resistance to tenofovir, an antiretroviral drug vital to most modern HIV treatment and prevention strategies, is surprisingly and worryingly common according to a large study led by UCL and funded by the Wellcome Trust.

Related Drug Resistance Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...